Morningstar

Cencora Inc COR

Morningstar Rating
Unlock
Stock XNYS Rating as of
$221.64 −2.59 (1.16%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Cencora Enjoys Robust Top-Line Growth From GLP-1s and Specialty Drugs but Sees Margin Headwinds

Keonhee Kim

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $200 billion in annual US healthcare distribution sales, the company supplies roughly one third of the domestic drug distribution market. Its two close competitors are Cardinal Health and McKesson. Together, the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the US market.

Read Full Report

Price vs Fair Value

View History
COR is trading at a 698% premium.
Price
$221.64
Fair Value
$582.00
Uncertainty
Medium
1-Star Price
$816.58
5-Star Price
$135.20
Economic Moat
Pybpfh
Capital Allocation
Fkzzpsvn

Bulls Say, Bears Say

Bulls

Cencora distributes pharmaceutical products to nearly one third of the industry, leading to substantial negotiation leverage with generic drug manufacturers.

Bears

Reimbursement pressures on pharmacy and provider customers have led to an emphasis on cost containment, pressuring Cencora's profitability.

Show More

News

View All

Trading Information

Previous Close Price
$224.23
Day Range
$221.39–223.60
52-Week Range
$178.46–247.66
Bid/Ask
$220.15 / $223.07
Market Cap
$43.44 Bil
Volume/Avg
1.8 Mil / 1.4 Mil

Key Statistics

Price/Earnings (Normalized)
16.69
Price/Sales
0.16
Dividend Yield (Trailing)
0.92%
Dividend Yield (Forward)
0.92%
Total Yield
3.82%

Company Profile

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Mid Core
Total Number of Employees
46,000
Website
https://www.cencora.com

Competitors

Valuation

View More
Metric
COR
CAH
MCK
Price/Earnings (Normalized)
 16.6914.7517.44
Price/Book Value
 47.19——
Price/Sales
 0.160.120.21
Price/Cash Flow
 14.1312.0914.31
Price/Earnings
COR
CAH
MCK

Financial Strength

Metric
COR
CAH
MCK
Quick Ratio
 0.520.480.46
Current Ratio
 0.890.980.93
Interest Coverage
 9.3924.5514.09
Quick Ratio
COR
CAH
MCK

Profitability

Metric
COR
CAH
MCK
Return on Assets (Normalized)
 4.19%4.13%5.53%
Return on Equity (Normalized)
 324.13%——
Return on Invested Capital (Normalized)
 48.02%109.00%64.65%
Return on Assets
COR
CAH
MCK

Medical Distribution Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
McKesson Corp
MCK
WlfltccxFgrht$63.4 Bil
 Cardinal Health Inc
CAH
XfcckzklHwnkzl$26.7 Bil
 Shanghai Pharmaceuticals Holding Co Ltd Class H
SHPMF
—Txqb$10.0 Bil
 Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H
SHPMY
—Fgsd$10.0 Bil
 Sinopharm Group Co Ltd
SHTDF
—Bzlkkly$8.8 Bil
 Sinopharm Group Co Ltd ADR
SHTDY
—Dbvgb$8.8 Bil
 Amplifon SpA Az nom Post Frazionamento
AMFPF
—Ncsjjl$6.5 Bil
 Ebos Group Ltd ADR
EBOSY
—Znxfwk$4.5 Bil
 Medipal Holdings Corp ADR
MAHLY
—Pwft$3.7 Bil

Sponsor Center